<DOC>
	<DOCNO>NCT00361374</DOCNO>
	<brief_summary>This study examine difference effectiveness two natural compound , eicosapentanoic ( EPA ) docosahexanoic ( DHA ) omega-3 fatty acid , treat major depressive disorder . Both type omega-3 fatty acid commonly find fish oil . It believe deficiency omega-3 fatty acid may lead development major depression .</brief_summary>
	<brief_title>Safety Effectiveness Omega 3-Fatty Acids , EPA Versus DHA , Treatment Major Depression</brief_title>
	<detailed_description>The study last eight week involve four visit screen baseline visit ( biweekly ) . Participants randomize , choose chance , enter one three group . People first group take 1 g/day EPA omega-3 fatty acid , second group take 1 g/day DHA omega-3 fatty acid , third group take placebo . This study double-blind , mean neither participant , doctor , research staff know group person . At end study participant offer three month follow-up care Depression Clinical Research Program .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Men woman age 1880 year old . Must meet criterion current Major Depressive Disorder . Serious unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic , hematologic disease History seizure disorder . Substance use disorder , include alcohol , active within last six month ( past history OK ) . History multiple adverse drug reaction allergy study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Depression</keyword>
	<keyword>Omega-3</keyword>
	<keyword>Boston</keyword>
</DOC>